Specially, in NSCLC, the tumor progression and metastasis are considered to be associated with the mutations of some tumor suppressor genes, such as p53, and the mutation of p53 induces VEGF gene expression [27]. The gene discussed is TP53; the disease is non-small cell lung carcinoma.